Newsletter | August 21, 2023

08.21.23 -- Can Advances In Nanoparticle Engineering Technology Improve New Drug Candidate Success Rates?

How Approved Drugs Have Evolved Since The '70s

Drugs have become more lipophilic and complex in structure over time due to the industry’s move away from natural products. Despite this shift, fully synthetic drugs continue to grow in diversity and complexity. Innovative strategies are needed to improve bioavailability of these new drugs.

Solid Form Strategies For Increasing Oral Bioavailability

Optimizing a drug’s solid form can improve its solubility and bioavailability when further molecular modifications are prohibitive. The Nanoform team reviews solid form strategies for increasing the solubility and oral bioavailability of small molecule drugs.

Paving The Way For Tomorrow’s Medicines

Innovative technologies are necessary to improve the success rate of new drug candidates and push novel therapies to market. Recent advances in nanoparticle engineering technology promise to accomplish this.

How Can Nanoparticle Engineering Make The Difference For Alzheimer’s?

Commercial insights officer Jamie Unwin discusses the power of innovative nanoparticle engineering technology and AI-based digital twins.

Request Information